Cargando…
The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions
INTRODUCTION AND OBJECTIVE: European Union legislation has mandated the submission of European Economic Area non-serious reports to the EudraVigilance database since November 2017. As spontaneous reports of suspected adverse reactions to medicines represent a key source of safety signals, the Europe...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763735/ https://www.ncbi.nlm.nih.gov/pubmed/34881404 http://dx.doi.org/10.1007/s40264-021-01137-0 |
_version_ | 1784634015052988416 |
---|---|
author | Candore, Gianmario Monzon, Sebastian Slattery, Jim Piccolo, Loris Postigo, Rodrigo Xurz, Xavier Strauss, Sabine Arlett, Peter |
author_facet | Candore, Gianmario Monzon, Sebastian Slattery, Jim Piccolo, Loris Postigo, Rodrigo Xurz, Xavier Strauss, Sabine Arlett, Peter |
author_sort | Candore, Gianmario |
collection | PubMed |
description | INTRODUCTION AND OBJECTIVE: European Union legislation has mandated the submission of European Economic Area non-serious reports to the EudraVigilance database since November 2017. As spontaneous reports of suspected adverse reactions to medicines represent a key source of safety signals, the European Medicines Agency has undertaken this work to assess the effects of this requirement on the characteristics of the reports submitted to EudraVigilance and on the detection of adverse drug reactions through routine analyses of the database. METHODS: Changes in the numbers of serious and non-serious reports transmitted to EudraVigilance were examined over the period during which the legislation was implemented. The numbers and nature of potential safety signals emerging from established statistical algorithms used at the European Medicines Agency applied either to only the serious reports or to all reports in EudraVigilance were compared. RESULTS: Up to November 2017, less than 25% of European Economic Area reports in EudraVigilance were classified as non-serious, since than this figure was slightly above 60%. This change accompanied an increase in the total number of reports received. Addition of non-serious reports to the signal detection process resulted in a small overall increase in signals of disproportionate reporting with some new signals of disproportionate reporting appearing and some existing signals of disproportionate reporting disappearing; the sensitivity of the signal detection system was slightly increased and the proportion of signals of disproportionate reporting that corresponded to known adverse drug reactions (a measure of efficiency) was unchanged. CONCLUSIONS: The change in legislation has led to a small increase in sensitivity, without affecting the efficiency of the routine statistical measures used. The number of non-serious reports as a proportion of reports in EudraVigilance is likely to increase over time and further monitoring of the impact on signal detection is required. Further work is also required on the qualitative impact of non-serious reports on the nature of signals detected and on their evaluation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40264-021-01137-0. |
format | Online Article Text |
id | pubmed-8763735 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-87637352022-01-31 The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions Candore, Gianmario Monzon, Sebastian Slattery, Jim Piccolo, Loris Postigo, Rodrigo Xurz, Xavier Strauss, Sabine Arlett, Peter Drug Saf Original Research Article INTRODUCTION AND OBJECTIVE: European Union legislation has mandated the submission of European Economic Area non-serious reports to the EudraVigilance database since November 2017. As spontaneous reports of suspected adverse reactions to medicines represent a key source of safety signals, the European Medicines Agency has undertaken this work to assess the effects of this requirement on the characteristics of the reports submitted to EudraVigilance and on the detection of adverse drug reactions through routine analyses of the database. METHODS: Changes in the numbers of serious and non-serious reports transmitted to EudraVigilance were examined over the period during which the legislation was implemented. The numbers and nature of potential safety signals emerging from established statistical algorithms used at the European Medicines Agency applied either to only the serious reports or to all reports in EudraVigilance were compared. RESULTS: Up to November 2017, less than 25% of European Economic Area reports in EudraVigilance were classified as non-serious, since than this figure was slightly above 60%. This change accompanied an increase in the total number of reports received. Addition of non-serious reports to the signal detection process resulted in a small overall increase in signals of disproportionate reporting with some new signals of disproportionate reporting appearing and some existing signals of disproportionate reporting disappearing; the sensitivity of the signal detection system was slightly increased and the proportion of signals of disproportionate reporting that corresponded to known adverse drug reactions (a measure of efficiency) was unchanged. CONCLUSIONS: The change in legislation has led to a small increase in sensitivity, without affecting the efficiency of the routine statistical measures used. The number of non-serious reports as a proportion of reports in EudraVigilance is likely to increase over time and further monitoring of the impact on signal detection is required. Further work is also required on the qualitative impact of non-serious reports on the nature of signals detected and on their evaluation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40264-021-01137-0. Springer International Publishing 2021-12-08 2022 /pmc/articles/PMC8763735/ /pubmed/34881404 http://dx.doi.org/10.1007/s40264-021-01137-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Article Candore, Gianmario Monzon, Sebastian Slattery, Jim Piccolo, Loris Postigo, Rodrigo Xurz, Xavier Strauss, Sabine Arlett, Peter The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions |
title | The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions |
title_full | The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions |
title_fullStr | The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions |
title_full_unstemmed | The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions |
title_short | The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions |
title_sort | impact of mandatory reporting of non-serious safety reports to eudravigilance on the detection of adverse reactions |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763735/ https://www.ncbi.nlm.nih.gov/pubmed/34881404 http://dx.doi.org/10.1007/s40264-021-01137-0 |
work_keys_str_mv | AT candoregianmario theimpactofmandatoryreportingofnonserioussafetyreportstoeudravigilanceonthedetectionofadversereactions AT monzonsebastian theimpactofmandatoryreportingofnonserioussafetyreportstoeudravigilanceonthedetectionofadversereactions AT slatteryjim theimpactofmandatoryreportingofnonserioussafetyreportstoeudravigilanceonthedetectionofadversereactions AT piccololoris theimpactofmandatoryreportingofnonserioussafetyreportstoeudravigilanceonthedetectionofadversereactions AT postigorodrigo theimpactofmandatoryreportingofnonserioussafetyreportstoeudravigilanceonthedetectionofadversereactions AT xurzxavier theimpactofmandatoryreportingofnonserioussafetyreportstoeudravigilanceonthedetectionofadversereactions AT strausssabine theimpactofmandatoryreportingofnonserioussafetyreportstoeudravigilanceonthedetectionofadversereactions AT arlettpeter theimpactofmandatoryreportingofnonserioussafetyreportstoeudravigilanceonthedetectionofadversereactions AT candoregianmario impactofmandatoryreportingofnonserioussafetyreportstoeudravigilanceonthedetectionofadversereactions AT monzonsebastian impactofmandatoryreportingofnonserioussafetyreportstoeudravigilanceonthedetectionofadversereactions AT slatteryjim impactofmandatoryreportingofnonserioussafetyreportstoeudravigilanceonthedetectionofadversereactions AT piccololoris impactofmandatoryreportingofnonserioussafetyreportstoeudravigilanceonthedetectionofadversereactions AT postigorodrigo impactofmandatoryreportingofnonserioussafetyreportstoeudravigilanceonthedetectionofadversereactions AT xurzxavier impactofmandatoryreportingofnonserioussafetyreportstoeudravigilanceonthedetectionofadversereactions AT strausssabine impactofmandatoryreportingofnonserioussafetyreportstoeudravigilanceonthedetectionofadversereactions AT arlettpeter impactofmandatoryreportingofnonserioussafetyreportstoeudravigilanceonthedetectionofadversereactions |